gene_symbol
TNF
hgnc_id
HGNC:11892
binding_type
receptor ligand recognition
cytotoxicity
NO
cytotoxicity_type
INDIRECT
cytotoxicity_mechanism
Infliximab neutralizes soluble TNF-α and blocks TNFR signaling; it does not directly engage or kill cells via the soluble target. Any direct cytotoxicity occurs only when binding transmembrane TNF (reverse signaling/ADCC), not the soluble form.
enzyme_product
Off
epitope
Off
variant
Off
isoform
Off
hla_specific
Off
gated
Off
other_modifier
Soluble TNF (sTNF)
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT05781152
disease_id_num_tar_ref
2258
drug_id_num_tar_ref
6041